Yahoo Poland Wyszukiwanie w Internecie

Search results

1. immunecyte.comDeveloping Best-In-Class Immunotherapy - ImmuneCyte

   immunecyte.com

   • Zapisane w pamięci cache

   16 kwi 2020 · ImmuneCyte Inc. is a global, clinical-stage biopharmaceutical company engaged in the research and development of innovative cell and gene therapeutics, including chimeric antigen receptor (CAR)-T cell, CAR-NK cell, and mononuclear cell therapies, for the treatment of cancer, vascular, orthopedic and aging-related diseases.

2. www.dnb.com › business-directory › company-profilesImmuneCyte Inc. Company Profile | Irvine, CA - Dun & Bradstreet

   www.dnb.com › business-directory › company-profiles

   • Zapisane w pamięci cache

   Find company research, competitor information, contact details & financial data for ImmuneCyte Inc. of Irvine, CA. Get the latest business insights from Dun & Bradstreet.

3. www.crunchbase.com › organization › immunecyteImmuneCyte - Crunchbase Company Profile & Funding

   www.crunchbase.com › organization › immunecyte

   • Zapisane w pamięci cache

   ImmuneCyte is a multilingual, clinical-stage biopharmaceutical firm dedicated to the study and creation of alternative cell and gene medicines, such as CAR-NK, mononuclear, and T cells with chimeric antigen receptors, for the treatment of cancer, vascular, orthopaedic, and age-related illnesses.

4. pitchbook.com › profiles › companyImmuneCyte Life Sciences Company Profile 2024: Valuation, Funding...

   pitchbook.com › profiles › company

   • Zapisane w pamięci cache

   13 kwi 2020 · General Information. Description. Provider of immune cell banking services committed to offering cell-based immunotherapy treatment solutions to clients. The company through its thermogenesis' proprietary car-txpress platform, aims to provide immune cells storage services at a tangibly lower cost. Contact Information. Website. www.immunecyte.com.

5. rocketreach.co › immunecyte-inc-profile_b42283fafeec3044Company Information - RocketReach

   rocketreach.co › immunecyte-inc-profile_b42283fafeec3044

   • Zapisane w pamięci cache

   ImmuneCyte Inc. is a global, clinical-stage biopharmaceutical company engaged in the research and development of innovative cell and gene therapeutics, including the fourth generation chimeric antigen receptor (CAR)-T cell, CAR-NK cell, and mononuclear cell therapies, for the treatment of cancer and vascular diseases.

6. www.cbinsights.com › company › immunecyte-life-sciencesImmuneCyte Life Sciences - Products, Competitors, Financials,...

   www.cbinsights.com › company › immunecyte-life-sciences

   • Zapisane w pamięci cache

   ImmuneCyte Life Sciences is a clinical-stage biopharmaceutical company focused on developing innovative cell and gene therapeutics for the treatment of cancer, vascular, orthopedic, and aging-related diseases.

7. immunecyte.com › healthbanks-subsidiary-immunecyte-acquires-boyalifes-cellularHealthBanks’ Subsidiary ImmuneCyte Acquires Boyalife’s Cellular...

   immunecyte.com › healthbanks-subsidiary-immunecyte-acquires-boyalifes-cellular

   • Zapisane w pamięci cache

   8 mar 2021 · IRVINE, Calif., March 08, 2021 – HealthBanks Biotech (USA), Inc. (“HealthBanks” or the “Company”), a premium cell banking network, today announced that through its subsidiary, ImmuneCyte Inc. (“ImmuneCyte”), the Company has executed an acquisition agreement with Boyalife Group (“Boyalife”) to acquire the entire Boyalife ...